Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
19.91
-0.09 (-0.45%)
At close: Oct 5, 2026, 4:00 PM EDT
19.95
+0.04 (0.20%)
Pre-market: Oct 6, 2026, 4:41 AM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.18 billion as of October 5, 2026. Its market cap has increased by 41.16% in one year.
Market Cap
3.18B
Enterprise Value
2.28B
1-Year Change
41.16%
Ranking
Category
Stock Price
$19.91
ChartMarket Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.18B, an increase of 68.64%. That is a compound annual growth rate of 6.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 3.18B | 31.44% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 3.60B |
| Telix Pharmaceuticals | 3.58B |
| Celcuity | 3.53B |
| Viking Therapeutics | 3.49B |
| Enliven Therapeutics | 3.44B |
| Acadia Pharmaceuticals | 3.44B |
| Tarsus Pharmaceuticals | 3.20B |
| Arcutis Biotherapeutics | 3.16B |